Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1Cin pancreatic endocrine tumors
Open Access
- 12 August 2011
- journal article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 11 (1), 351
- https://doi.org/10.1186/1471-2407-11-351
Abstract
RASSF1A gene silencing by DNA methylation has been suggested as a major event in pancreatic endocrine tumor (PET) but RASSF1A expression has never been studied. The RASSF1 locus contains two CpG islands (A and C) and generates seven transcripts (RASSF1A-RASSF1G) by differential promoter usage and alternative splicing. We studied 20 primary PETs, their matched normal pancreas and three PET cell lines for the (i) methylation status of the RASSF1 CpG islands using methylation-specific PCR and pyrosequencing and (ii) expression of RASSF1 isoforms by quantitative RT-PCR in 13 cases. CpG island A methylation was evaluated by methylation-specific PCR (MSP) and by quantitative methylation-specific PCR (qMSP); pyrosequencing was applied to quantify the methylation of 51 CpGs also encompassing those explored by MSP and qMSP approaches. MSP detected methylation in 16/20 (80%) PETs and 13/20 (65%) normal pancreas. At qMSP, 11/20 PETs (55%) and 9/20 (45%) normals were methylated in at least 20% of RASSF1A alleles. Pyrosequencing showed variable distribution and levels of methylation within and among samples, with PETs having average methylation higher than normals in 15/20 (75%) cases (P = 0.01). The evaluation of mRNA expression of RASSF1 variants showed that: i) RASSF1A was always expressed in PET and normal tissues, but it was, on average, expressed 6.8 times less in PET (P = 0.003); ii) RASSF1A methylation inversely correlated with its expression; iii) RASSF1 isoforms were rarely found, except for RASSF1B that was always expressed and RASSF1C whose expression was 11.4 times higher in PET than in normal tissue (P = 0.001). A correlation between RASSF1A expression and gene methylation was found in two of the three PET cell lines, which also showed a significant increase in RASSF1A expression upon demethylating treatment. RASSF1A gene methylation in PET is higher than normal pancreas in no more than 75% of cases and as such it cannot be considered a marker for this neoplasm. RASSF1A is always expressed in PET and normal pancreas and its levels are inversely correlated with gene methylation. Isoform RASSF1C is overexpressed in PET and the recent demonstration of its involvement in the regulation of the Wnt pathway points to a potential pathogenetic role in tumor development.Keywords
This publication has 35 references indexed in Scilit:
- Molecular Profiling and Classification of Sporadic Renal Cell Carcinoma by Quantitative Methylation AnalysisClinical Cancer Research, 2004
- Tumor suppressor RASSF1A is a microtubule-binding protein that stabilizes microtubules and induces G2/M arrestOncogene, 2004
- Promoter Hypermethylation of Resected Bronchial MarginsClinical Cancer Research, 2004
- A Role for the RASSF1A Tumor Suppressor in the Regulation of Tubulin Polymerization and Genomic StabilityCancer Research, 2004
- Early Occurrence of RASSF1A Hypermethylation and Its Mutual Exclusion with BRAF Mutation in Thyroid TumorigenesisCancer Research, 2004
- Control of microtubule stability by the RASSF1A tumor suppressorOncogene, 2003
- Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.2003
- Sensitive and quantitative universal Pyrosequencing™ methylation analysis of CpG sitesBioTechniques, 2003
- Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samplesOncogene, 2003
- Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences of the United States of America, 1996